UCIBIO is parte of the PROSPLIGN project awarded 3.4 M€
The PROSPLIGN project - PROSPecting natural LIGNin biodiversity towards unlocking value-added bioactive motifs and molecules – is an European funded Research and Innovation Action project awarded €3.4 Million euros and has officially kicked off in Dublin last week.
Arménio Barbosa awarded CPU and GPU time from RNCA for the SpikeLig project
Arménio Barbosa, researcher at the Biomolecular Engineering Lab, was awarded 100k and 2k hours of CPU and GPU time for the SpikeLig project, from RNCA, FCT, I.P..
UCIBIO-NOVA FCT technology for cancer treatment licensed to BioNTech by CellmAbs
CellmAbs, a spin-off biotech company from Universidade NOVA de Lisboa, announced on 9 January that it has entered into a patent assignment and license agreement with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.
Cecília Roque receives an ERC Proof of Concept grant
Cecília Roque, leader of the Biomolecular Engineering Laboratory at UCIBIO-NOVA FCT was distinguished with a European Research Council (ERC) Proof of Concept grant with the project UNMASK: Unraveling Parkinson ́s disease diagnostic. This is the researcher’s third ERC Grant, ensuring continuous funding from the council since 2014 for her work in non-invas